抗衰老初创获1亿美元C轮融资,预计未来2年内启动3项临床试验
https://www.longevity.technology/cambrian-closes-100m-to-advance-therapeutics-to-clinic/
https://www.longevity.technology/cambrian-biopharma-james-peyer-qa/
https://xueqiu.com/4739855805/196153925
赞 (0)
https://www.longevity.technology/cambrian-closes-100m-to-advance-therapeutics-to-clinic/
https://www.longevity.technology/cambrian-biopharma-james-peyer-qa/
https://xueqiu.com/4739855805/196153925